Goldman Raises Price Target on Alkermes (ALKS) Following Close of Elan Drug Merger

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. DE
9. OSIS
10. REAX

Go back to Goldman Raises Price Target on Alkermes (ALKS) Following Close of Elan Drug Merger
ALKERMES (NASDAQ: ALKS) Delayed: 48.33 +0.31 (0.65%)
Previous Close $48.02    52 Week High $80.71 
Open $48.05    52 Week Low $27.14 
Day High $48.67    P/E 371.77 
Day Low $47.33    EPS $0.13 
Volume 939,640